L. Browne

L. Browne

Chief Executive Officer at
Rythera Therapeutics, Inc.

Net worth: 817 992 $ as of 2026-06-29

65 year
Health Technology
Commercial Services
Consumer Services

Profile

L.
Daniel Browne
was the founder of Revance Therapeutics, Inc., founded in 1999, where the titles held included President, Chief Executive Officer & Director from 2014 to 2019.
Mr. Browne was the founder of Avava, Inc., founded in 2020, serving as Director from 2020 to 2022.
Current jobs include Chairman & Chief Executive Officer at Rythera Therapeutics, Inc. since 2020, Director at Galderma Holding SA, and Independent Director at Galderma Group AG since 2022.
Former jobs include President & Chief Executive Officer at Neomend, Inc. from 2001 to 2003, President & Chief Executive Officer at Prograft Medical, Inc. from 1997 to 2000, and Business Leader at W.
L.
Gore & Associates, Inc. Education includes undergraduate studies at the University of Hawai'i at Hilo and an MBA from Pepperdine Graziadio Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0%
2025-12-30 3,588 ( 0% ) 817 992 $ 2026-06-29

L. Browne active positions

CompaniesPositionStart
Director/Board Member -
Chief Executive Officer -

Former positions of L. Browne

CompaniesPositionEnd
Founder 2022-04-30
REVANCE THERAPEUTICS, INC. Founder 2019-10-13
Chief Executive Officer -
Prograft Medical, Inc.
Chief Executive Officer -
Corporate Officer/Principal -
See the detail of L. Browne's experience

Training of L. Browne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

38

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Health Technology

Prograft Medical, Inc.

Health Technology

Consumer Services

Technology Services

Commercial Services